Literature DB >> 20857777

Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.

O C Oguejiofor1, C U Odenigbo, C B N Oguejiofor.   

Abstract

BACKGROUND AND OBJECTIVES: Risk factors predisposing to foot ulceration in diabetic subjects are multiple. Long duration of diabetes mellitus is a major risk factor, likewise peripheral neuropathy (PN), which globally, is recognized as the commonest risk factor for foot disease in diabetic subjects. OBJECTIVES: To evaluate the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom Screening Test (UKST) Scoring System, Bio-thesiometry and Aesthesiometry, in Nigerian diabetic subjects without current or previous foot ulceration. SUBJECTS AND METHODS: One hundred and twenty (120) diabetes mellitus (DM) subjects with and without symptoms of peripheral neuropathy receiving care at the medical outpatient department (MOPD) and the diabetic clinic of the Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria, were recruited consecutively as they presented. Data collected included subjects age (years), gender, age at first diagnosis of DM, duration of DM (years) and baseline fasting venous plasma glucose. The United Kingdom Screening Test (UKST) symptom score was used to separate the participants into two groups those with symptoms of PN and those without and the subjects further assessed by three methods the UKST Signs score, Bio-thesiometry and Aesthesiometry to determine the presence . of PN.
RESULTS: Among the 120 diabetic participants, 83(69.2%) had neuropathic symptoms (the symptomatic participants) while 37 (30.8%) were asymptomatic (the asymptomatic participants). The different methods of diagnosing PN increasingly detected PN with increasing duration of diabetes. For the symptomatic group, the UKST method detected PN least in those with duration of DM <5 years (73.9%) and 100.0% in those with duration of DM >15 years while for the asymptomatic group, it detected PN in 25.0% of those with duration of DM <5 years, and 100.0% for those with duration of DM >15 years. For the symptomatic group, Aesthesiometry detected PN in 65.2% of those with duration of DM <5 years and 91.7% in those with duration of DM >15 years. For the asymptomatic group, it detected PN in 29.2% of those with duration of DM <5 years and 100.0% in those with duration of DM >15 years. Likewise, for the symptomatic group, Bio-thesiometry detected PN in 47.8% of those with duration of DM <5 years and 100.0% in those with duration of DM >15 years. For the asymptomatic group, it detected PN in 16.7% of those with duration of DM <5 years and 100.0% in those with duration of DM >15 years.
CONCLUSION: Long duration of diabetes mellitus and peripheral neuropathy are risk factors for foot complication in Nigerians with diabetes mellitus. Diabetic subjects with long duration of diabetes (>10 years) almost always have associated peripheral neuropathy, and should be recognized as a special group at high risk for foot disease from DM. Specific preventive programs should target this group to reduce the rate of avoidable loss of limbs to diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20857777

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  9 in total

1.  Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.

Authors:  Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

2.  Prevalence of neuropathy in patients with type 2 diabetes in Iran : A systematic review and meta-analysis.

Authors:  Dariush Afshari Aliabadi; Nasrin Moradian; Elham Rahmanian; Masoud Mohammadi
Journal:  Wien Klin Wochenschr       Date:  2020-12-17       Impact factor: 1.704

3.  Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control.

Authors:  Muhammad Umer Nisar; Ambreen Asad; Ahmed Waqas; Nazia Ali; Anam Nisar; Mohsin A Qayyum; Hafsa Maryam; Mohsin Javaid; Mohsin Jamil
Journal:  Cureus       Date:  2015-08-12

4.  Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital.

Authors:  Anthonia O Ogbera; Olufunmilayo Adeleye; Babatunde Solagberu; Alfred Azenabor
Journal:  BMC Res Notes       Date:  2015-10-04

5.  Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy.

Authors:  Hamid R Fateh; Seyed Pezhman Madani; Ramin Heshmat; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2016-03-25

6.  Relationship between subclinical hypothyroidism and distal-symmetric diabetic polyneuropathy in type 2 diabetes mellitus referred to Kosar Hospital in Semnan and related indicators in 2019-2020.

Authors:  Sara Reshdat; Mohammad Mehri; Shahryar Pourkalhor; Atousa Najmaldin; Majid Foroutan
Journal:  J Family Med Prim Care       Date:  2022-03-18

7.  The Relationship Between Depression and Multifactorial Control and Microvascular Complications in Vietnamese with Type 2 Diabetes Mellitus Aged 30-60 Years.

Authors:  Tuan Dinh Le; Hoang Huy Duong; Ly Thi Nguyen; Nga Phi Thi Nguyen; Son Tien Nguyen; Manh Van Ngo
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-18       Impact factor: 3.249

8.  Association of serum calprotectin with peripheral neuropathy in patients with type 2 diabetes mellitus.

Authors:  Ramanathan Velayutham; Pradeep Pankajakshan Nair; Prashant S Adole; Vadivelan Mehalingam
Journal:  J Family Med Prim Care       Date:  2021-04-29

9.  Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Yeshamble Work; Yared Asmare Aynalem
Journal:  BMC Endocr Disord       Date:  2020-04-15       Impact factor: 2.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.